Robert W. Duggan
Co-CEO & Executive ChairmanMr. Robert W. Duggan, also known as Bob, had been an Interim Principal Financial Officer at Summit Therapeutics Inc. since July 02, 2021. He has been Co-Chief Executive Officer at Summit Therapeutics Inc. since July 27, 2022 and served as its Chief Executive Officer since April 2020. Since 2016, Mr. Duggan has been Chief Executive Officer of Duggan Investments, Inc. Mr. Duggan serves as Executive Chairman of Summit Therapeutics Inc. since February 26, 2020 and has been its and Director since December 2019 and served as its Non-Executive Director since December 24, 2019 until February 26, 2020. He is Co-owner of Genius, Inc. Mr. Duggan has been the Chief Executive Officer and Director of Duggan Investment Inc. He served as Independent Chairman of the Board at Pulse Biosciences, Inc. since November 2, 2017 until September 2022 and serves as its Independent Co-Chairman since August 2024 and served as its Executive Chairman from September 2022 until August 2024. He served as the Chief Executive Officer at Pharmacyclics LLC (Alternate name: Pharmacyclics Inc.) since February 12, 2009 until May 2015. Mr. Duggan is an entrepreneur with multiple successful companies to his credit, spanning communication technology, outdoor media, surgical robotics and pharmaceuticals. He served as an Interim Chief Financial Officer of Pharmacyclics Inc. since October 31, 2008 and served as its Interim Chief Executive Officer from September 10, 2008 to February 12, 2009. Mr. Duggan served as Chief Executive Officer of Computer Motion, Inc. since 1997 until 2003. He founded Robert W. Duggan & Associates. He served as Secretary at Artificial Life, Inc. He has participated as a Director and Advisor to numerous small and large businesses in the medical equipment, technology, digital encryption, consumer retail goods, PC hardware and software distribution, computer local and wide area network and outdoor media communication industries. He has also assisted in corporate planning, capital formation and management for his various investments. He served as the Chairman of Pharmacyclics Inc. and of MAG International. He served as the Chairman of Computer Motion Inc. from 1990 to 2003 and also served as its Director. He had been a Director of Pharmacyclics Inc. since September 19, 2007 until May 2015. He served as a Director of Intuitive Surgical Inc. from June 2003 to April 21, 2011. Mr. Duggan serves as a Member of the University of California at Santa Barbara Foundation Board of Trustees. He serves as a Director of Radial Medical, Inc. Genuine First Aid International, Medical Distribution Industries, Blazon Corporation, Blaze-On Corporation, Oxstem Limited and Robert W. Duggan Foundation. He served as a Director of Genoscience Pharmaceuticals and Human Longevity, Inc. Mr. Duggan received a U.S. Congressman Medal of Merit from Ron Paul in 1985 and in 2000 he was named a Knight of the Legion D’Honor by President Jacques Chirac of France.
Positions
- Company NameSummit Therapeutics Inc.Stock CodeSMMTPositionCo-CEO & Executive Chairman
- Company NamePulse Biosciences, Inc.Stock CodePLSEPositionIndependent Co-ChairmanColleagues
- PAPaul Arthur LaViolettePresident, CEO & Co-Chairman of the Board
- RWRobert W. DugganIndependent Co-Chairman
- JSJon SkinnerChief Financial Officer
- DRDarrin R. UeckerCTO & Director
- LTLiane TeplitskyChief Operating Officer
- STSteven T. WeberVP of Accounting, Principal Accounting Officer & Global Corporate Controller
- MSManmeet Singh SoniLead Independent Director
- MZMahkam ZanganehIndependent Director
